Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Abscess × Adalimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 7 Spondylitis, Ankylosing 2 Psoriasis 2 Colitis, Ulcerative 2 Sarcoidosis 1 Plaque Psoriasis 1 Nephrotic Syndrome 1 Nephrosis, Lipoid 1 Mucopolysaccharidosis VI 1 Mucopolysaccharidosis II 1 Mucopolysaccharidosis I 1 Mucopolysaccharidoses 1 Macular dystrophy, corneal type 1 1 Kidney Diseases 1 Inflammation 1 Hidradenitis Suppurativa 1 Glomerulosclerosis, Focal Segmental 1 Dupuytren Contracture 1 Crohn Disease 1 Arthritis, Psoriatic 1 Acne Vulgaris 1 Abscess 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01635764 2018-01-24

PIONEER (OLE)

AbbVie

Phase 3 Completed

508 enrolled 9 charts

Abscess, Acne Vulgaris, Hidradenitis Suppurativa

Data powered by HemOnc (CC BY 4.0) Colophon ⚡